© 2021 New Statesman Media Group Ltd, Studio 5 Salters House, 156 High Street, Hull, United Kingdom, HU1 1NQ

Register Now

FOLLOW US ON

Who attends?

This conference is a unique way to educate and engage with policymakers, business figures and industry experts on the challenges and opportunities facing the sector.

Our Sponsors

We are proud to be supported by great companies. If you would like to sponsor an event please get in touch with Mark.Buller@ns-mediagroup.com

BioTechnology Conference

In this virtual event, New Statesman Spotlight will convene leaders from politics, business, and academia to discuss the future of biotechnology in Britain. This ambitious online series will examine the challenges and issues facing sector leaders, as well as the policy decisions that can support a thriving industry in post-Covid Britain.

Key topics

  • Emerging trends in research and development
  • Data reporting, surveys, and statistics
  • Analysis of sectors including life sciences, manufacturing, agriculture, and energy
  • Emerging technologies, such as automation, AI and VR

Overview

The biotech sector has been at the forefront of fighting the pandemic, from underpinning strategic research to its application in pharmaceuticals and drug production. The sector now has an opportunity to facilitate a sustainable recovery in the aftermath of the covid-19 crisis; whether through producing biofuels or using biomanufacturing to improve production processes, biotech offers innovative solutions. But collaboration between universities, business and policymakers needs to be maintained and expanded to decarbonise industry and make full use of the sector.  Will the Covid-19 crisis act as a catalyst to accelerate the adoption of biotechnology by society? And what is currently limiting the uptake of biotechnology across sectors? 

Speakers Include

This event is free to attend 

Agenda

2:00pm - 2:30pm

Keynote Opening Address: The Role of Biotech in the Coronavirus Recovery

George Freeman, Former Minister for Life Sciences

Chair: Dimi Reider, Special Projects Editor, New Statesman

As we look towards life after the pandemic, can investing in biotechnology boost our overall economic recovery? A keynote interview and live Q&A.  

3:15pm -4:00pm

The Future of Medical Biotechnology 

Andy Topping, Chief Scientific Officer, Fujifilm Diosynth Biotechnologies 

Chair: Dimi Reider, Special Projects Editor, New Statesman

Biotech plays an increasingly important role in medical treatment, from innovating gene therapy to treat metabolic diseases, to creating new vaccines. What is the future role of biotech in medicine? A panel discussion and live Q&A.  

2:30pm - 3:15pm

Using Biotechnology to Transition to Net Zero

Dr Martin Hayes, Biotechnology Lead, Johnson Matthey

Professor Nigel Scrutton, University of Manchester

Matthew Jones, Principal Synthetic Biologist at Cambridge Consultants 

Chair: Sonja van Renssen, Managing Editor, Energy Monitor

UK industry is directly responsible for a quarter of the UK’s greenhouse gas emissions. But agricultural biotech could help reduce emissions and increase food security for a growing population, by creating products and processes based on renewables. How can we use biotechnology to take the UK towards net zero carbon? And can biotech be used to create a circular economy? A panel discussion and live Q&A.  

Register Here

15 July 2021 | 14:00 - 17:45 BST

Why attend?

Leaders from politics, business, and academia

Online Conference

Register here

Places will be allocated on a first-come, first-served basis, register today to secure your place.

4:00pm -4:45pm

Is Biotechnology the Next Step in Manufacturing? 

Professor Lionel Clarke, Chair, UK Engineering Biology Leadership Council

Conor McKechnie, Vice President of Marketing, Cytivia

Chair: Dimi Reider, Special Projects Editor, New Statesman

As development into human health products like vaccines and antibody tests surged during the pandemic, biotech was central to manufacturing. As we consider the post pandemic recovery, what will biotech manufacturing look like and will it broaden its scope into other sectors? A panel discussion and live Q&A. 

4:45pm -5:30pm

Biotech Innovation and Investment

Gordon Lundie, Senior Director of Market Access and Pricing, Gilead  

Professor Joyce Tait, Director, Innogen Centre, University of Edinburgh

Chi Onwurah MP, Shadow Minister for Science, Research and Digital

Chair: Lara Williams, Senior Reporter, Investment Monitor

Rapid innovation has been key in the Covid-19 response, with biotechnology having a key role to play in conducting research and development. How can the private and public sector collaborate to continue the upwards trend of investment and innovation in biotech? A panel discussion and live Q&A. 

Find out more
Find out more
Find out more
Find out more
Find out more

Professor Nigel Scrutton

Director

EPSRC Future Biomanufacturing Research Hub

Speaker Bio

Professor Lionel Clarke

 Chair of the Engineering Biology Leadership Council

Speaker Bio

Professor Joyce Tait

 Founding Director of the Innogen Institute

University of Edinburgh

Speaker Bio

Conor McKechnie

Vice President Marketing

Cytiva

Speaker Bio

Dr Martin Hayes

 Biotechnology Lead

Johnson Matthey

Speaker Bio

Chi Onwurah MP

Shadow Minister for Science, Research and Digital

Speaker Bio

George Freeman

Former Minister for Life Sciences

Speaker Bio

Andy Topping

Chief Scientific Officer 

Fujifilm Diosynth Biotechnologies  

Speaker Bio
Find out more

Sonja van Renssen

Managing Editor

Energy Monitor

Speaker Bio

Lara Williams

Senior Reporter

Investment Monitor

Speaker Bio

Dimi Reider

Special Projects Editor

New Statesman

Speaker Bio

5:30pm- 5:45pm 

Keynote Closing Address

Nadhim Zahawi MP, Minister for BEIS and Covid-19 Vaccine Deployment

Chair: Dimi Reider, Special Projects Editor, New Statesman

Nadhim Zahawi MP

Minister for BEIS and Covid-19 Vaccine Deployment

Speaker Bio

Matthew Jones

Principal Synthetic Biologist at Cambridge Consultants 

Speaker Bio

For any enquiries about the event, contact Dominic.Rae@newstatesman.co.uk

Conor.Diggin@ns-mediagroup.com


Contact us

Gordon Lundie

Senior Director of Market Access and Pricing, Gilead

Speaker Bio